Root joint involvement in spondyloarthritis: a post hoc analysis from the international ASAS-PerSpA study.


Journal

Rheumatology (Oxford, England)
ISSN: 1462-0332
Titre abrégé: Rheumatology (Oxford)
Pays: England
ID NLM: 100883501

Informations de publication

Date de publication:
02 02 2022
Historique:
received: 22 02 2021
revised: 20 04 2021
pubmed: 28 4 2021
medline: 11 3 2022
entrez: 27 4 2021
Statut: ppublish

Résumé

The primary objective was to compare the clinical characteristics of SpA patients with and without root joint disease (RJD+ and RJD-). The secondary objectives were to compare the prevalence of RJD across various SpA subtypes and in different world regions, and to compare the SpA axial severity and SpA burden between RJD+ and RJD-. This is a post hoc analysis of the Assessment of Spondyloarthritis International Society PerSpA study (PERipheral involvement in SpondyloArthritis), which included 4465 patients with SpA [axial (axSpA), peripheral (pSpA), PsA, IBD, reactive and juvenile] according to the rheumatologist's diagnosis. RJD was defined as the 'ever' presence of hip or shoulder involvement related to SpA, according to the rheumatologist. Patient characteristics were compared between RJD+ and RJD-. Multivariable stepwise binary logistic regression analyses were conducted to identify factors associated with 'RJD', 'hip' and 'shoulder' involvement. RJD was significantly associated with the SpA main diagnosis (highest in pSpA), a higher prevalence of HLA-B27 positivity, enthesitis, tender and swollen joints, CRP, conventional synthetic DMARDs, loss of lumbar lordosis and occiput-wall distance >0. RJD was more prevalent in Asia, and occurred in 1503 patients (33.7%), with more hip (24.2%) than shoulder (13.2%) involvement. Hip involvement had a distinct phenotype, similar to axSpA (including younger age at onset, HLA-B27 positivity), whereas shoulder involvement was associated with features of pSpA (including older age at onset). RJD+ SpA patients had a distinctive clinical phenotype compared with RJD-. Hip involvement, based on the rheumatologist's diagnosis, was more prevalent than shoulder involvement and was clinically distinct.

Identifiants

pubmed: 33905488
pii: 6255772
doi: 10.1093/rheumatology/keab380
doi:

Types de publication

Journal Article Multicenter Study Observational Study Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

667-678

Informations de copyright

© The Author(s) 2021. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For permissions, please email: journals.permissions@oup.com.

Auteurs

Nelly Ziadé (N)

Rheumatology, Saint-Joseph University.
Rheumatology, Hotel-Dieu de France Hospital.

Jean El Hajj (J)

Rheumatology, Saint-Joseph University.
Rheumatology, Hotel-Dieu de France Hospital.

Joe Rassi (J)

Rheumatology, Saint-Joseph University.
Rheumatology, Hotel-Dieu de France Hospital.

Sani Hlais (S)

Rheumatology, Saint-Joseph University.
Rheumatology, American University of Beirut, Beirut, Lebanon.

Clementina López-Medina (C)

Rheumatology Department, Cochin Hospital, Paris, France.
Rheumatology Department, Reina Sofia University Hospital/IMIBIC/University of Cordoba, Cordoba, Spain.

Sherif M Gamal (SM)

Rheumatology Department, Cairo University, Cairo, Egypt.

Bassel Elzorkany (B)

Rheumatology Department, Cairo University, Cairo, Egypt.

Maxime Dougados (M)

Department of Rheumatology, Hôpital Cochin, Assistance Publique-Hôpitaux deParis-INSERM (U1153), Clinical Epidemiology and Biostatistics, PRES Sorbonne Paris-Cité, Université de Paris.

Xenofon Baraliakos (X)

Rheumazentrum Ruhrgebiet Herne, Ruhr-University Bochum, Bochum, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH